AC Immune (ACIU) Operating Expenses (2015 - 2026)
AC Immune (ACIU) posted quarterly Operating Expenses of -$20.3 million for Q1 2026, up 10.3% year-over-year from -$18.4 million in Q1 2025, and down 10.21% quarter-over-quarter from -$18.4 million in Q4 2025.
AC Immune (ACIU) Operating Expenses (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Operating Expenses for 12 consecutive years, with -$20.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 10.3% year-over-year to -$20.3 million; the TTM figure through Mar 2026 stood at -$85.1 million (up 5.58% YoY), while the FY2025 annual figure was -$87.9 million, up 3.35% from the prior year.
- Operating Expenses declined to -$20.3 million in Q1 2026 per ACIU's latest filing, from -$18.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at -$17.5 million in Q3 2023 and bottomed at -$25.0 million in Q2 2025.
- Historically, Operating Expenses has averaged -$20.8 million across 5 years, with a median of -$20.6 million in 2022.
- Annual changes were most pronounced in 2022 — Operating Expenses gained 21.46% — and 2024, when it slipped 26.27%.
- AC Immune's Operating Expenses stood at -$19.4 million in 2022, then dropped by 6.54% to -$20.7 million in 2023, then dropped by 9.06% to -$22.6 million in 2024, then increased by 18.26% to -$18.4 million in 2025, then declined by 10.21% to -$20.3 million in 2026.
- Business Quant data shows ACIU's Operating Expenses at -$20.3 million in Q1 2026, -$18.4 million in Q4 2025, and -$21.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | 57.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.86 Mn |
| Mar 31, 2026 | -20.31 Mn |
| Dec 31, 2025 | -18.43 Mn |
| Sep 30, 2025 | -21.38 Mn |
| Jun 30, 2025 | -25.00 Mn |
| Mar 31, 2025 | -22.65 Mn |
| Dec 31, 2024 | -22.55 Mn |
| Sep 30, 2024 | -21.03 Mn |
| Jun 30, 2024 | -23.94 Mn |
| Mar 31, 2024 | -22.99 Mn |
| Dec 31, 2023 | -20.68 Mn |
| Sep 30, 2023 | -17.51 Mn |
| Jun 30, 2023 | -18.96 Mn |
| Mar 31, 2023 | -19.00 Mn |
| Dec 31, 2022 | -19.41 Mn |
| Sep 30, 2022 | -18.01 Mn |
| Jun 30, 2022 | -20.62 Mn |
| Mar 31, 2022 | -20.39 Mn |
| Dec 31, 2021 | -24.71 Mn |
| Sep 30, 2021 | -22.09 Mn |